Ph.D., Head of Global Biomarker Research, Bayer
Dr. Thomas Krahn is heading the department of Global Biomarker Research within Bayer Pharma AG. The main task of this department is translational research supporting early clinical trials by identification and qualification of specific biomarkers and evaluation of new technologies. The focus of his activities is on less invasive procedures to define biomarkers which can be used to predict and/or monitor response treatment and support patient stratification for targeted therapies.
CTCs: Capturing, Cultivation and Molecular Analysis
In-depth analysis and comparison of different principles for capturing of viable circulating tumor cells will be presented. A novel ex vivo culturing platform and respective approach toward the enrichment and molecular profiling of CTC clusters will be explained. Aim of the molecular analysis of CTCs is to provide relevant and actionable information critical for clinical decision making.